Your browser doesn't support javascript.
loading
Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium.
Javaheripour, Nooshin; Li, Meng; Chand, Tara; Krug, Axel; Kircher, Tilo; Dannlowski, Udo; Nenadic, Igor; Hamilton, J Paul; Sacchet, Matthew D; Gotlib, Ian H; Walter, Henrik; Frodl, Thomas; Grimm, Simone; Harrison, Ben J; Wolf, Christian Robert; Olbrich, Sebastian; van Wingen, Guido; Pezawas, Lukas; Parker, Gordon; Hyett, Matthew P; Sämann, Philipp G; Hahn, Tim; Steinsträter, Olaf; Jansen, Andreas; Yuksel, Dilara; Kämpe, Robin; Davey, Christopher G; Meyer, Bernhard; Bartova, Lucie; Croy, Ilona; Walter, Martin; Wagner, Gerd.
Afiliación
  • Javaheripour N; Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.
  • Li M; Clinical Affective Neuroimaging Laboratory (CANLAB), Leipziger Str. 44, Building 65, 39120, Magdeburg, Germany.
  • Chand T; Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.
  • Krug A; Clinical Affective Neuroimaging Laboratory (CANLAB), Leipziger Str. 44, Building 65, 39120, Magdeburg, Germany.
  • Kircher T; Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.
  • Dannlowski U; Clinical Affective Neuroimaging Laboratory (CANLAB), Leipziger Str. 44, Building 65, 39120, Magdeburg, Germany.
  • Nenadic I; Department of Psychiatry and Psychotherapy, University of Bonn, 53127, Bonn, Germany.
  • Hamilton JP; Department of Psychiatry and Psychotherapy, Philipps Universität Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
  • Sacchet MD; Department of Psychiatry and Psychotherapy, Philipps Universität Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
  • Gotlib IH; Institute for Translational Psychiatry, University of Münster, 48149, Münster, Germany.
  • Walter H; Department of Psychiatry and Psychotherapy, Philipps Universität Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
  • Frodl T; Center for Social and Affective Neuroscience, Center for Medical Image Science and Visualization, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Grimm S; Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
  • Harrison BJ; Department of Psychology, Stanford University, Bldg. 420, Jordan Hall, Stanford, CA, 94305, USA.
  • Wolf CR; Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany.
  • Olbrich S; Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Leipzigerstr. 44, 39120, Magdeburg, Germany.
  • van Wingen G; Department of Psychiatry and Psychotherapy, CBF, Charité Universitätsmedizin Berlin, 12203, Berlin, Germany.
  • Pezawas L; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Victoria, Australia.
  • Parker G; Center for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany.
  • Hyett MP; Department of Psychiatry, Psychotherapy and Psychosomatic, University Zürich, Zürich, Switzerland.
  • Sämann PG; Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Hahn T; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
  • Steinsträter O; School of Psychiatry, AGSM Building, University of New South Wales, Sydney, Australia.
  • Jansen A; School of Psychological Sciences, University of Western Australia, Perth, Australia.
  • Yuksel D; Max Planck Institute of Psychiatry, Munich, Germany.
  • Kämpe R; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Davey CG; Department of Psychiatry and Psychotherapy, Philipps Universität Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
  • Meyer B; Department of Psychiatry and Psychotherapy & Marburg Center for Mind, Brain and Behavior - MCMBB, Philipps- Universität Marburg, Marburg, Germany.
  • Bartova L; Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA, USA.
  • Croy I; Center for Social and Affective Neuroscience, Center for Medical Image Science and Visualization, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Walter M; Department of Psychiatry, The University of Melbourne, Victoria, Australia.
  • Wagner G; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
Transl Psychiatry ; 11(1): 511, 2021 10 07.
Article en En | MEDLINE | ID: mdl-34620830
ABSTRACT
Major depressive disorder (MDD) is associated with abnormal neural circuitry. It can be measured by assessing functional connectivity (FC) at resting-state functional MRI, that may help identifying neural markers of MDD and provide further efficient diagnosis and monitor treatment outcomes. The main aim of the present study is to investigate, in an unbiased way, functional alterations in patients with MDD using a large multi-center dataset from the PsyMRI consortium including 1546 participants from 19 centers ( www.psymri.com ). After applying strict exclusion criteria, the final sample consisted of 606 MDD patients (age 35.8 ± 11.9 y.o.; females 60.7%) and 476 healthy participants (age 33.3 ± 11.0 y.o.; females 56.7%). We found significant relative hypoconnectivity within somatosensory motor (SMN), salience (SN) networks and between SMN, SN, dorsal attention (DAN), and visual (VN) networks in MDD patients. No significant differences were detected within the default mode (DMN) and frontoparietal networks (FPN). In addition, alterations in network organization were observed in terms of significantly lower network segregation of SMN in MDD patients. Although medicated patients showed significantly lower FC within DMN, FPN, and SN than unmedicated patients, there were no differences between medicated and unmedicated groups in terms of network organization in SMN. We conclude that the network organization of cortical networks, involved in processing of sensory information, might be a more stable neuroimaging marker for MDD than previously assumed alterations in higher-order neural networks like DMN and FPN.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Conectoma Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Transl Psychiatry Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Conectoma Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Transl Psychiatry Año: 2021 Tipo del documento: Article